key: cord-0683085-4moor54v authors: Buyck, Michael; Levy, Arielle; Tabone, Laurence; Aubin, Carl-Eric; Jouvet, Philippe; Baudin, Florent title: Pediatric barrier enclosure for nasopharyngeal suctioning during Covid-19 pandemic: A simulation based-study date: 2020-12-11 journal: Am J Emerg Med DOI: 10.1016/j.ajem.2020.11.077 sha: 1b7b50d898562c340c95172c11bf265adf6c0b7a doc_id: 683085 cord_uid: 4moor54v nan Pediatric barrier enclosure for nasopharyngeal suctioning during Covid-19 pandemic: A simulation based-study Nasopharyngeal Suctioning (NS) is a common procedure for upper respiratory tract infections in children. However, this procedure represents a risk of transmission of SARS-Cov-2 [1] during fall and upcoming winter seasons as flu and Covid-19 diseases are concomitant, and symptoms are similar [2] . In addition to the use of Personal Protective Equipment (PPE), plastic barrier enclosure was designed to reduce the risk of transmission during intubation of Covid-19 patients, mainly in the operating room and intensive care unit [3] . It is a large plexiglass box installed above the head and torso of a patient lying supine during advanced airway procedure. However, barrier enclosure has not been evaluated for common pediatric procedures in emergency department. In this context, we aimed to evaluate the benefit of a pediatric barrier enclosure for NS as an additional protection for healthcare providers (HCP). An experimental descriptive simulation-based study assessing the impact of the barrier enclosure on droplet dispersion was conducted during a NS. First, our barrier enclosure was adapted by coinvestigators in this study for the pediatric context (see Appendix 1), and renamed Splash Guard for Care Givers (SG-CG): -Smaller size and additional openings to allow for multiple HCP to intervene simultaneously on a child -A HEPA filter port to connect to a suction with a negative flow within the box (up to 90 L/min) -Optional press-fit plugs to close unused openings Design is available in an open-access format to be reproduced and used by others HCP. Ethic board approval was not required because no patients or participants were involved. To simulate the NS procedure, we mixed a fluorescent solution of 50% Glow Germ® solution with 50% Normal Saline. We connected a 50 ml syringe to two laryngo-tracheal mucosal atomization devices (MADgic®, Teleflex Medical, Morrisville, USA) inserted under the skin until the probe reached the manikin's mouth and the right nostril. During the procedure, we intermittently pushed the plunger of the syringe, simulating sneezing and coughing through both atomization devices. Immediately after each experience, we compared dispersion of droplets with and without the SG-CG using UV light to reveal the fluorescent droplets. Between each procedure, PPEs were changed, and the manikin, the environment, and the SG-CG were cleaned. In the absence of the SG-CG, we observed a significant presence of fluorescent droplets in the environment, on the HCP's PPE (Fig. 1a) face and neck. With the SG-CG, the contamination remained only on HCP's gloves and the close environment of the manikin inside the SG-CG (Fig. 1b) . Video recordings of the simulations are available (Fig. 2) . To our knowledge, the present study is the first application of a pediatric barrier enclosure for common emergency procedure. We demonstrated that the SG-CG added a significant protection of HCP performing a NS on a pediatric manikin. It decreased the risk of contamination of the uncovered skin on the HCP's neck, and it may prevent risk of re-contamination during PPE removal [4] by decreasing the amount of contamination of the PPE. Our experimentation demonstrated protection for large droplets, but we were unable to evaluate aerosol protection. Even if we expect low aerosol accumulation for short airway procedures as NS, we recommend using the SG-CG with a HEPA filter port and negative pressure in case of extended airway procedures in accordance with FDA recent alerts [5] . The SG-CG is an easy, safe, and affordable barrier protection for common procedures performed in all settings caring for children. SG-CG is currently used in the ED at our institution. It may prove to be beneficial to HCPs over the next months, considering viral respiratory infections symptoms merge with those of Covid-19 [6] . Michael Buyck designed the study, contributed to the organization, and drafted the initial manuscript, and reviewed and revised the manuscript. Arielle Levy, and Florent Baudin conceptualized the study, initiated the study, designed the study, contributed to the organization, and reviewed and revised the manuscript. Laurence Tabone, Carl-Eric Aubin, and Philippe Jouvet designed the study, and reviewed and revised the manuscript. All the authors approved the final manuscript and agree to be accountable for all aspects of the work. Clinical Questions about COVID-19: Questions and Answers Comparison of clinical features of COVID-19 vs seasonal influenza A and B in US children Aerosol boxes and barrier enclosures for airway management in COVID-19 patients: a scoping review and narrative synthesis Exposure to a surrogate measure of contamination from simulated patients by emergency department personnel wearing personal protective equipment Protective Barrier Enclosures Without Negative Pressure Used During the COVID-19 Pandemic May Increase Risk to Patients and Health Care Providers -Letter to Health Care Providers. FDA Double threat of COVID-19 and influenza We thank the support team at the CHU Ste-Justine Mother-child Simulation Center Ms. Guylaine Neuveu (Clinical Simulation Educator) and Mr. Bertrand Vaillancourt (Audiovisual and Simulation Technician) for their support. Supplementary data to this article can be found online at https://doi. org/10.1016/j.ajem.2020.11.077.